share_log

中基長壽科學:盈利警告

ZHONG JI LS: PROFIT WARNING

HKEX ·  Mar 19 13:04

Summary by Moomoo AI

中基長壽科學集團發佈盈利警告,預計2024財年將錄得純損約3200萬至3500萬港元,以及公司擁有人應佔純損約3200萬至3500萬港元。相比之下,2023財年曾錄得純利約250萬港元及公司擁有人應佔溢利約230萬港元。預期虧損主要歸因於三個因素:一是公司一間附屬公司就約10.76億港元長期未償還貸款在多個司法管轄區進行追繳所產生的一次性法律及服務費用約2040萬港元;二是集團在中國的長壽科學業務就MNM補充品所產生的重大市場營銷活動成本;三是撤銷MNM膳食補充品零售業務的影響。公司預計將於2025年3月28日或之前公佈2024財年的詳細財務業績。
中基長壽科學集團發佈盈利警告,預計2024財年將錄得純損約3200萬至3500萬港元,以及公司擁有人應佔純損約3200萬至3500萬港元。相比之下,2023財年曾錄得純利約250萬港元及公司擁有人應佔溢利約230萬港元。預期虧損主要歸因於三個因素:一是公司一間附屬公司就約10.76億港元長期未償還貸款在多個司法管轄區進行追繳所產生的一次性法律及服務費用約2040萬港元;二是集團在中國的長壽科學業務就MNM補充品所產生的重大市場營銷活動成本;三是撤銷MNM膳食補充品零售業務的影響。公司預計將於2025年3月28日或之前公佈2024財年的詳細財務業績。
The ZHONG JI LS Group has issued a profit warning, expecting to record a net loss of about 32 million to 35 million Hong Kong dollars for the fiscal year 2024, and a net loss attributable to shareholders of about 32 million to 35 million Hong Kong dollars. In contrast, a net profit of about 2.5 million Hong Kong dollars and a profit attributable to shareholders of about 2.3 million Hong Kong dollars were recorded for the fiscal year 2023.The expected loss is mainly attributed to three factors: first, a one-time legal and service fee of about 20.4 million Hong Kong dollars incurred by the company's subsidiary for the collection of long-term unpaid loans of about 1.076 billion Hong Kong dollars across multiple jurisdictions; second, the significant marketing costs of the longevity science business in China related to MNM supplements; third, the impact of the withdrawal of the MNM dietary supplement Retail Trade business. The company expects to announce the detailed financial results for the fiscal year 2024 on or before March 28, 2025.
The ZHONG JI LS Group has issued a profit warning, expecting to record a net loss of about 32 million to 35 million Hong Kong dollars for the fiscal year 2024, and a net loss attributable to shareholders of about 32 million to 35 million Hong Kong dollars. In contrast, a net profit of about 2.5 million Hong Kong dollars and a profit attributable to shareholders of about 2.3 million Hong Kong dollars were recorded for the fiscal year 2023.The expected loss is mainly attributed to three factors: first, a one-time legal and service fee of about 20.4 million Hong Kong dollars incurred by the company's subsidiary for the collection of long-term unpaid loans of about 1.076 billion Hong Kong dollars across multiple jurisdictions; second, the significant marketing costs of the longevity science business in China related to MNM supplements; third, the impact of the withdrawal of the MNM dietary supplement Retail Trade business. The company expects to announce the detailed financial results for the fiscal year 2024 on or before March 28, 2025.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 399

Recommended

Statement

This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.